Impact of immunosuppressant therapy on new-onset diabetes in liver transplant recipients
Fu-Chao Liu,1,2,* Huan-Tang Lin,1,2,* Jr-Rung Lin,1–3 Huang-Ping Yu1,2 1Department of Anesthesiology, Chang Gung Memorial Hospital, 2College of Medicine, 3Clinical Informatics and Medical Statistics Research Center and Graduate Institute of Clinical Medicine, Chang Gung Universit...
Main Authors: | Liu FC, Lin HT, Lin JR, Yu HP |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-08-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/impact-of-immunosuppressant-therapy-on-new-onset-diabetes-in-liver-tra-peer-reviewed-article-TCRM |
Similar Items
-
Incidence of new-onset diabetes among sudanese renal transplant patients using different immunosuppressive regimens: A retrospective study
by: Alaa Mohammedazeem Elzain, et al.
Published: (2021-01-01) -
Posttransplant Diabetes Mellitus and Immunosuppression Selection in Older and Obese Kidney RecipientsPlain-Language Summary
by: David A. Axelrod, et al.
Published: (2022-01-01) -
Immunosuppressive regimens on conversion of cytomegalovirus infection to disease in liver transplant recipients
by: Amirhassan Rabbani, et al.
Published: (2022-09-01) -
A Time-Based Meta-Analysis on the Incidence of New Onset Diabetes after Liver Transplantation
by: Yip Han Chin, et al.
Published: (2021-03-01) -
New-Onset Diabetes after Kidney Transplantation: Diagnosis, Risk Factors, and Management
by: Tomislav Bulum, et al.
Published: (2021-01-01)